IPP Bureau
Laurus Labs, Unitaid and Clinton Health Access Initiative to develop HIV medication for children
By IPP Bureau - September 14, 2021
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
.jpg "BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer")
BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer
By IPP Bureau - September 14, 2021
In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).
Prevest DenPro Limited's IPO to open on BSE SME platform on September 15
By IPP Bureau - September 14, 2021
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
ENTOD Pharma launches surgical division HyTek
By IPP Bureau - September 14, 2021
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
CSIR-NEERI transfers Saline Gargle RT-PCR technology to the MSME ministry
By IPP Bureau - September 13, 2021
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
Precision care Ethos therapy debuts in Taiwan
By IPP Bureau - September 13, 2021
Incorporating multi-modality image guidance, Ethos therapy provides the ability to personalize the patient's treatment based on their anatomy and position at the time of treatment
Boehringer Ingelheim and Twist Bioscience ink antibody discovery collaboration
By IPP Bureau - September 13, 2021
Research collaboration covers multiple antibody research programs
Zydus Cadila seeks approval for a two-dose ZyCoV-D Covid-19 vaccine
By IPP Bureau - September 13, 2021
The three-dose vaccine approved for EUA contains 2mg for each dose, whereas the two-dose plan will have 3mg in each dose.
Shalby Hospital opens its first orthopaedic and joint replacement franchisee in Udaipur, Rajasthan
By IPP Bureau - September 13, 2021
The hospital through its network performs more than 10,000 joint replacement surgeries annually
Innova Medical Group donates GBP 10 million to launch The Pandemic Institute, Liverpool
By IPP Bureau - September 13, 2021
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
Granules India recalls one batch of Naproxen Sodium 220mg tablets
By IPP Bureau - September 13, 2021
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Advanced Enzyme supplements pass clinical trials for efficacy
By IPP Bureau - September 13, 2021
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
Everest Medicines ties up with Providence Therapeutics to supply Covid-19 vaccines in Asia
By IPP Bureau - September 13, 2021
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma
By IPP Bureau - September 12, 2021
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
US FDA grants Jardiance Breakthrough Therapy designation for heart failure with a preserved ejection fraction
By IPP Bureau - September 12, 2021
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
